Showing results (61-70 of 255) with videos related to
Sort By:
Pageof 26
The Cochrane Database of Systematic Reviews|March 4, 2021
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.The Cochrane Database of Systematic Reviews|January 22, 2010
Treatment for Barrett's oesophagusJonathan Re Rees, Pierre Lao-Sirieix, Angela Wong, et al.Journal of Cellular and Molecular Medicine|April 16, 2008
Progressive silencing of p14ARF in oesophageal adenocarcinomaYinghui Huang, Christopher J Peters, Rebecca C Fitzgerald, et al.Annual Review of Medicine|November 20, 2020
Hereditary Diffuse Gastric Cancer: Approaches to Screening, Surveillance, and TreatmentNastazja Dagny Pilonis, Marc Tischkowitz, Rebecca C Fitzgerald, et al.Nature Reviews. Clinical Oncology|November 11, 2025
The biology and therapeutic implications of heterogeneity in Barrett oesophagus and oesophageal adenocarcinomaDylan P McClurg, Sally Pan, Rebecca C Fitzgerald, et al.Neoplasia (New York, N.Y.)|February 22, 2005
Cell cycle phase abnormalities do not account for disordered proliferation in Barrett's carcinogenesisPierre Lao-Sirieix, Rebecca Brais, Laurence Lovat, et al.Current Opinion in Systems Biology|January 4, 2019
Evolutionary dynamics in pre-invasive neoplasiaChristopher Abbosh, Subramanian Venkatesan, Samuel M Janes, et al.Gastroenterology|January 19, 2010
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagusStuart Jon Spechler, Rebecca C Fitzgerald, Ganapathy A Prasad, et al.Journal of Clinical Pathology|June 26, 2019
Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR studyYiwang Xu, Ahmad Miremadi, Alexander Link, et al.Plos One|February 1, 2007
Selective loss of TGFbeta Smad-dependent signalling prevents cell cycle arrest and promotes invasion in oesophageal adenocarcinoma cell linesBenjamin A Onwuegbusi, Jonathan R E Rees, Pierre Lao-Sirieix, et al.Pageof 26